Hypoactive Sexual Desire Disorder (HSDD) Clinical Trial
Official title:
Acupuncture in Premenopausal Women With Hypoactive Sexual Desire Disorder: A Prospective Cohort
Female Sexual Dysfunction (FSD) affects up to 43% of women in the United States and Hypoactive Sexual Desire Disorder (HSDD) is the most common form. There is no standardized treatment for this condition. We know that alternative therapies such as acupuncture have been beneficial to women suffering from urinary incontinence, chronic lower back pain, and migraines. We hypothesize that the quality of life for premenopausal women with hypoactive sexual desire disorder (HSDD) will improve with initiation of acupuncture therapy for a duration of 5-weeks. Validated questionnaires are administered at the time of enrollment and 1 week after the final acupuncture session as the method of analyzing our primary outcome.
Each woman will receive experimental therapy with acupuncture twice a week for five weeks
and complete a packet of validated questionnaires/surveys at the 1st visit in person and at
week 6 by mail.
The acupuncture sessions include:
- An Initial Evaluation in which the certified acupuncturist will take a
- History including: chief complaint, diet, level of diaphoresis, water intake, digestive
function, menstrual cycling, sleep habits, overall mood
- Physical Exam: inspection of tongue and palpation of pulse
- 25 minutes of resting quietly with acupuncture needles in place
- Needle usage: from8 to 20 needles are typically used, with an average of 14 per session
- Needles are typically placed on the scalp, lower abdomen, elbows and knees
Subsequent Sessions (9 more) with the certified acupuncturist
- 25 minute each, twice weekly, for 5 weeks = total 10 sessions
- Needle usage = 8-20, average 14 per session
- Typically placed on the scalp, lower abdomen, elbows and knees
The questionnaires/surveys include questions about:
- Sexual desire, arousal, lubrication, orgasm, satisfaction and pain
- General physical health
- General emotional and psychological health
- Social relationships
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03619005 -
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
|
Phase 3 | |
Completed |
NCT03080298 -
Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
|
Phase 2 | |
Completed |
NCT00349791 -
Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
|
Phase 3 | |
Completed |
NCT01702818 -
Stress Hormones, Mood and Women's Sexual Desire (MODEST)
|